Baron & Budd Attorney and Shareholder Burton LeBlanc to Speak on Opioid Epidemic at American Association for Justice
BATON ROUGE, La. – November 17, 2017 – The national law firm of Baron & Budd is pleased to...READ MORE
You may have heard about the link between the anti-depressant Abilify and compulsive gambling and had a skeptical reaction. However, a recent U.S. Food and Drug Administration (FDA) warning may change your mind about that link.
The FDA warns that use of Abilify, the brand name of the drug aripiprazole, can lead to not only an uncontrollable urge to gamble but also several other impulse control problems. According to the warning, there have been many reports of people who experienced these issues only to see their urges disappear completely after discontinuing their use of the drug.
Abilify is used to treat several mental conditions, including Tourette’s syndrome, schizophrenia and bipolar disorder. In some instances it is used in combination with another anti-depressant. According to the FDA warning, Abilify can decrease symptoms such as disorganized thinking as well as hallucinations.
However, the FDA recommends that doctors and other healthcare providers inform patients about the risk of impulse control issues associated with Abilify, and ask patients currently on the drug whether or not they are experiencing uncontrollable urges. Anyone who is taking the drug should first talk to his or her doctor before discontinuing use, according to the FDA.
According to the agency’s statement, the FDA is now requiring that the risk of compulsive behavior be added to aripiprazole’s warning labels.
Unfortunately, many people have suffered substantial gambling losses after taking Abilify. These patients had no idea the drug could lead to this type of destructive behavior. If you experienced this problem, you may be able to take legal action against the manufacturer. Please contact Baron & Budd as soon as you can to learn more about your potential options. Give us a call at 866-520-2755 or complete our contact form to contact us online.